ELV

ELV

USD

Elevance Health Inc. Common Stock

$316.620+6.160 (1.984%)

Real-time Price

Healthcare
Healthcare Plans
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$310.460

High

$318.790

Low

$310.000

Volume

0.89M

Company Fundamentals

Market Cap

70.4B

Industry

Healthcare Plans

Country

United States

Trading Stats

Avg Volume

1.99M

Exchange

NYQ

Currency

USD

52-Week Range

Low $273.71Current $316.620High $458.75

Related News

Analyst Upgrades

Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400

Mizuho analyst Ann Hynes maintains Elevance Health with a Outperform and lowers the price target from $420 to $400.

View more
Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400
Analyst Upgrades

JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394

JP Morgan analyst Lisa Gill maintains Elevance Health with a Overweight and raises the price target from $384 to $394.

View more
JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394
Analyst Upgrades

TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380

TD Cowen analyst Ryan Langston maintains Elevance Health with a Buy and raises the price target from $330 to $380.

View more
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380
Analyst Upgrades

Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403

Wells Fargo analyst Stephen Baxter maintains Elevance Health with a Overweight and lowers the price target from $412 to $403.

View more
Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403
Reuters

Elevance beats profit estimates as health insurer keeps costs in check

Elevance Health on Tuesday beat Wall Street estimates for third-quarter profit as the health insurer managed to keep medical costs in check, sending its shares 3% higher in premarket trading.

View more
Elevance beats profit estimates as health insurer keeps costs in check
Analyst Upgrades

Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $359

Morgan Stanley analyst Erin Wright maintains Elevance Health with a Equal-Weight and raises the price target from $316 to $359.

Analyst Upgrades

Goldman Sachs Initiates Coverage On Elevance Health with Neutral Rating, Announces Price Target of $343

Goldman Sachs analyst Scott Fidel initiates coverage on Elevance Health with a Neutral rating and announces Price Target of $343.